Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
8
×
life sciences
national blog main
san francisco blog main
8
×
vc
8
×
boston blog main
new york blog main
san diego blog main
national top stories
biotech
boston top stories
indiana blog main
new york top stories
raleigh-durham blog main
san diego top stories
san francisco top stories
seattle blog main
startups
venture capital
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana top stories
national
raleigh-durham top stories
seattle top stories
texas blog main
texas top stories
biogen
digital health
ipo
novartis
software
celgene
clinical trials
commissioner
cybersecurity
What
bio
roundup
healthcare
ipo
new
biogen
developing
drug
investors
medicine
medicines
million
patients
startup
therapeutics
years
activity
allogene
america
announced
approvals
backs
beta
bets
bigger
bionics
biopharma
blood
cancer
car
celgene
clamped
click
closed
colleagues
continues
convoluted
covid
crispr
daunting
Language
unset
Current search:
vc
×
fda
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets